 |
“We developed the optic nerve/osmotic pump infusion technique to deliver soluble ligands, agonists, or antagonists directly into the optic nerve.The advantages of this technique are that the infused drugs remain largely confined within the experimental nerve, reducing the impact of potential systemic side effects; mere placement of the catheter and subsequent infusion of the vehicle solution do not promote lesion-like changes within the optic nerve…” Rodgers et al., GLIA 41:180-190; 2003. |
 |

|
2008 Shows & Events
Event or Convention |
Location |
Exhibit Dates |
Exhibit No. |
| Society of Toxicology (SOT) |
Seattle, WA |
March 16-20 |
504 |
| Experimental Biology |
San Diego, CA |
April 5-9 |
802, 804 |
| American Association for
Cancer Research (AACR) |
San Diego, CA |
April 12-16 |
2301 |
| The Endocrine Society's
90th Annual Meeting (ENDO 2008) |
San Francisco, CA |
June 15-18 |
TBD |
Texas
Medical Center |
Houston,
TX |
August
14 |
TBD |
University
of Washington |
Seattle,
WA |
October
16 |
TBD |
| Oregon Health and Science University |
Portland, OR |
October 30 |
TBD |
| American Association for Laboratory
Animal Science (AALAS) |
Indianapolis, IN |
November 9-13 |
TBD |
| Society for Neuroscience (SFN) |
Washington, DC |
November 15-19 |
TBD |
|